Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Switzerland Supplementary Protection Certificates

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Supplementary Protection Certificates in Switzerland

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
Country Patent Number Supplementary Protection Certificate SPC Country SPC Description SPC Expiration
European Patent Office 1280520 C01280520/01 Switzerland PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012   Start Trial
European Patent Office 1809237 C01809237/01 Switzerland PRODUCT NAME: CICLOSPORIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66093 08.09.2016   Start Trial
European Patent Office 2216409 C02216409/01 Switzerland PRODUCT NAME: ALBUTREPENONACOG ALFA; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65743 30.08.2016   Start Trial
European Patent Office 1781688 C01781688/01 Switzerland PRODUCT NAME: CARFILZOMIB; REGISTRATION NO/DATE: SWISSMEDIC 65690 23.11.2015   Start Trial
European Patent Office 1581254 C01581254/01 Switzerland PRODUCT NAME: MICROPLASMIN (OCRIPLASMIN); REGISTRATION NO/DATE: SWISSMEDIC 63053 13.03.2014   Start Trial
European Patent Office 1689846 C01689846/01 Switzerland PRODUCT NAME: TRASTUZUMAB ENTANSINE; REGISTRATION NO/DATE: SWISSMEDIC 62892 02.05.2013   Start Trial
European Patent Office 1562968 C01562968/01 Switzerland PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: SWISSMEDIC 65183 17.12.2014   Start Trial
>Country >Patent Number >Supplementary Protection Certificate >SPC Country >SPC Description >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.